RippeB., KredietR.Peritoneal physiology-transport of solutes. In: GokalR., NolphK.D., eds. The textbook of peritoneal dialysis.Dordrecht, the Netherlands: Kluwer Academic Publishers, 1994; 69–113.
2.
NolphK.D., MillerF.N., PyleW.K., PopovichR.P., SorkinM.T.An hypothesis to explain the ultrafiltration characteristics of peritoneal dialysis.Kidney Int1981; 20: 543–8.
3.
TwardowskiZ.J., KhannaR., NolphK.D.Osmotic agents and ultrafiltration in peritoneal dialysis.Nephron1986; 42: 93–100.
4.
MistryC.D., MattickN.P., GokalR.Ultrafiltration with an iso-osmotic solution during long peritoneal dialysis exchanges.Lancet1987; ii: 178–82.
5.
MistryC.D., GokalR., PeersE.and the MIDAS study group. A randomized multicenter clinical trial comparing isosmolar Icodextrin with hyperosmolar glucose solutions in CAPD.Kidney Int1994; 46: 496–503.
FallerB., BurkeR., De LeoM., ShockleyT.R., MartisL.Use of maltodextrins and amino acids as alternate osmotic agents for PD.Perit Dial Int1994; 14(Suppl 1): S23.
8.
KoppleJ.D., BernardD., MessanaJ.Treatment of malnourished CAPD patients with an amino acid based dialysate.Kidney Int1995; 47: 1148–57.
KredietR.T., StruijikD.G., KoomenG.C.M., AriszL.Peritoneal kinetics during CAPD measured with intraperitoneal Dextran 70.Trans Am Soc Artif Intern Organs1991; 37: 662–7.
11.
BurkeR.A., HvlzdM.G., ShockleyT.R.Direct determination of polyglucose metabolises in plasma using anion exchange chromatography with pulsed amperometric detection.J Chroma1997. In press.
12.
MistryC.D., BhowmickB., AshmanR., UttleyL.Clinical studies of new icodextrin formulations.Perit Dial Int1994; 14(S2): S55–7.
13.
PeersE.M., ScrimgeourA.C., HaycoxA.R.Cost-containment in CAPD patients with ultrafiltration failure.Clin Drug Invest1995; 10: 53–8.
14.
MillarD.J.Glycation of albumin with icodextrin (Abstract).J Am Soc Nephrol1995; 6: 551.
15.
WilliamsP.F., MarlissE.B., OrenA.Amino acid absorption following intraperitoneal administration in CAPD patients.Perit Dial Bull1982; 2: 129–30.
16.
YoungG.A., DibbleJ.B., HobonS.M.The use of an amino-acid based CAPD fluid over 12 weeks.Nephrol Dial Transplant1989; 4: 285–92.
17.
HolmesC.J.Biocompatibility of peritoneal dialysis solutions.Perit Dial Int1993; 13: 88–94.
18.
De FijterC.W.H., VerbrughH.A., PetersE.D.J.. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD.Clin Nephrol1993; 39: 75–80.
19.
GokalR., MistryC.D., PeersE. and the Midas study group. Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD.Perit Dial Int1995; 15: 226–30.
